Health and Healthcare

Sanofi : SNY

All Sanofi Articles

195 Articles

Trey Thoelcke | Aug 10, 2012 at 9:51 AM EDT

Biotech: Dendreon and Regeneron Draw Short Interest

The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short…

Jon C. Ogg | Jul 23, 2012 at 11:26 AM EDT

How Much Money Has Buffett Lost Investing in Europe?

Warren Buffett of Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) is often considered the greatest investor in modern times. Some…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

Jon C. Ogg | Jun 4, 2012 at 8:42 AM EDT

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

We have several shares of biotech stocks on the move, but frankly the news from th American Society of Clinical…

Jon C. Ogg | May 15, 2012 at 5:05 PM EDT

Big Changes to Buffett and Berkshire Hathaway Stock Holdings, A to Z

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings for the…

Paul Ausick | May 10, 2012 at 11:03 AM EDT

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

The energy sector saw a lot of activity from short sellers in April, but other stocks saw some action as…

Douglas A. McIntyre | May 10, 2012 at 7:11 AM EDT

Sony’s Turnaround Dreams

Sony (NYSE: SNE) said it would finally turn around is prospects and make money in the next year. Bumbling CEO…

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Paul Ausick | Mar 26, 2012 at 11:51 AM EDT

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

An anti-cholesterol drug being co-developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has shown positive results in…

Jon C. Ogg | Feb 14, 2012 at 5:05 PM EST

Berkshire Hathaway & Buffett’s Stock Holdings ‘L to Z’ (BRK-B, BRK-A, LMCA, MA, MTB, MCO, PG, SNY, TMK, USB, USG, UPS, VRSK, V, WMT, WPO, WFC)

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of…

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

1 … 6 7 8 9 10 … 13

Sanofi : SNY

All Sanofi Articles

Biotech: Dendreon and Regeneron Draw Short Interest

How Much Money Has Buffett Lost Investing in Europe?

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

Big Changes to Buffett and Berkshire Hathaway Stock Holdings, A to Z

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

Sony’s Turnaround Dreams

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

Berkshire Hathaway & Buffett’s Stock Holdings ‘L to Z’ (BRK-B, BRK-A, LMCA, MA, MTB, MCO, PG, SNY, TMK, USB, USG, UPS, VRSK, V, WMT, WPO, WFC)

Short Sellers Help Push Dendreon Higher

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Sanofi : SNY

All Sanofi Articles

Biotech: Dendreon and Regeneron Draw Short Interest

How Much Money Has Buffett Lost Investing in Europe?

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

Big Changes to Buffett and Berkshire Hathaway Stock Holdings, A to Z

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

Sony’s Turnaround Dreams

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

Berkshire Hathaway & Buffett’s Stock Holdings ‘L to Z’ (BRK-B, BRK-A, LMCA, MA, MTB, MCO, PG, SNY, TMK, USB, USG, UPS, VRSK, V, WMT, WPO, WFC)

Short Sellers Help Push Dendreon Higher

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not